Correlation Between Sparta Capital and Transcode Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sparta Capital and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sparta Capital and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sparta Capital and Transcode Therapeutics, you can compare the effects of market volatilities on Sparta Capital and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sparta Capital with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sparta Capital and Transcode Therapeutics.

Diversification Opportunities for Sparta Capital and Transcode Therapeutics

0.38

Correlation Coefficient

Sparta Capital  Transcode Therapeutics

Weak diversification

The 3 months correlation between Sparta and Transcode is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Sparta Capital and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Sparta Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sparta Capital are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Sparta Capital i.e., Sparta Capital and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Sparta Capital and Transcode Therapeutics

Assuming the 90 days horizon Sparta Capital is expected to generate 1.02 times more return on investment than Transcode Therapeutics. However, Sparta Capital is 1.02 times more volatile than Transcode Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  1.03  in Sparta Capital on December 30, 2024 and sell it today you would lose (0.92) from holding Sparta Capital or give up 89.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sparta Capital  vs.  Transcode Therapeutics

Sparta Capital

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sparta Capital has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly uncertain basic indicators, Sparta Capital may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Transcode Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Sparta Capital and Transcode Therapeutics

The main advantage of trading using opposite Sparta Capital and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sparta Capital position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.

The idea behind Sparta Capital and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.